Comparison of estrogen receptor determinations by a biochemical ligand- binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

Cancer

Volumn 78, Issue 4, 1996, Pages 764-772

  Alberts, Steven R ^a   Ingle, James N ^a   Roche, Patrick R ^a   Cha, Stephen S ^a   Wold, Lester E ^a   Farr Jr , Gist H ^b   Krook, James E ^c   Wieand, H Sam ^a  

^a MAYO CLINIC   (United States)

^b Ochsner Comm Clin Oncol Prog N   (United States)

^c Duluth CCOP   (United States)

Author keywords

breast neoplasms; estrogen receptors; immunohistochemistry; node positive

Indexed keywords

ESTROGEN RECEPTOR; LIGAND; MONOCLONAL ANTIBODY;

ACCURACY; ADULT; ARTICLE; BREAST CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIGAND BINDING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR DENSITY; TREATMENT PLANNING;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CHARCOAL; CHEMOTHERAPY, ADJUVANT; DEXTRANS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PARAFFIN EMBEDDING; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, ESTROGEN; TIME FACTORS; TISSUE FIXATION;

EID: 0029737029     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960815)78:4<764::AID-CNCR12>3.0.CO;2-T     Document Type: Article

References (36)

1. Mansour EG, Gray R, Shatila AH, Osborne CK, Tormey DC, Gilchrist KW, et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med 1989;320:485-90.
2. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1-15.
3. Glick JH, Gelber RD, Goldhirsch A, Senn HJ. Adjuvant therapy of primary breast cancer. 4th International Conference on Adjuvant Therapy of Primary Breast Cancer St. Gallen, Switzerland. Ann Oncol 1992;3:801-7.
4. Wilbur DC, Willis J, Mooney RA, Fallon MA, Moynes R, di Sant'Agnese PA. Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay. Mod Pathol 1992;5:79-83.
5. Tesch M, Shawwa A, Henderson R. Immunohistochemical determination of estrogen and progesterone-receptor status in breast cancer. Am J Clin Pathol 1993;99:8-12.
6. Pertschuk LP, Kim Y-D, Axiotis CA, Braverman AS, Carter AC, Eisenberg KB, et al. Estrogen receptor immunocytochemistry: the promise and the perils. J Cell Biochem 1994;(Suppl)19:134-7.
7. Tubbs RR. An approach to preliminary studies of interlaboratory comparative results for estrogen and progesterone receptors. J Cell Biochem 1994;(Suppl)19:36-9.
8. Allred DC. Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer? Am J Clin Pathol 1992;99:1-3.
9. Stierer M, Rosen H, Weber R, Hanak H, Spona J, Tuchler H. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors. Ann Surg 1993;218:13-21.
10. Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisenberg KB, Carter AC, et al. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer 1990;66:1663-70.
11. Allred DC, Bustamante MA, Daniel CO, Gaskill HV, Cruz AB Jr. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance. Arch Surg 1990;125:107-13.
12. Shousha S, Stamp T, James KR, Alaghband-Zadeh J. Immunohistological study of oestrogen receptors in breast carcinomas that are biochemically receptor negative. J Clin Pathol 1990;43:239-42.
13. Charalambous D, Kitchen PR, Stillwell RG, Smart PJ, Rode J. A comparison between radioligand and immunohistochemical assay of hormone receptors in primary breast cancer. Aust N Z J Surg 1993;63:637-41.
14. Esteban JM, Ahn C, Battifora H, Felder B. Quantitative immunohistochemical assay for hormonal receptors: technical aspects and biological significance. J Cell Biochem 1994; (Suppl)19:138-45.
15. Ingle JN, Everson LK, Wieand HS, Martin JK, Votava HJ, Wold LE, et al. Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer. J Clin Oncol 1988;6:1388-96.
16. Ingle JN, Everson LK, Wieand HS, Cullinan SA, Wold LE, Hagen JB, et al. Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer. Cancer 1989;63:1257-64.
17. Witzig TE, Ingle JN, Schaid DJ, Wold LE, Barlow JF, Gonchoroff NJ, et al. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials. J Clin Oncol 1993;11:351-9.
18. SAS/STAT User's Guide Version 6, Vol. 1, 4th ed. Cary (NC): SAS Institute, Inc. 1990.
19. SAS/STAT User's Guide Version 6, Vol. 2, 4th ed. Gary (NC): SAS Institute, Inc. 1990.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JASA 1958;53:457-81.
21. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
22. Molino A, Micciolo R, Turazza M, Bonetti F, Piubello Q, Corgnati A, et al. Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat 1995;34:221-8.
23. Helle M, Helin M, Isola J, Helin H. Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters. J Cancer Res Clin Oncol 1989;115:361-5.
24. Soomro S, Shousha S, Sinnett HD. Oestrogen and progesterone receptors in screen-detected breast carcinoma: an immunohistological study using paraffin sections. Histopathology 1992;21:543-7.
25. Judd R. Advantages of an immunohistochemical estrogen receptor assay. South Med J 1991;84:853-6,861.
26. Snead DRJ, Bell JA, Dixon AR, Nicholson RI, Elston CW, Blarney RW, et al. Methodology of immunohistochemical detection of oestrogen receptor in human breast carcinoma in formalin-fixed, paraffin-embedded tissue: a comparison with frozen section methodology. Histopathology 1993; 23:233-8.
27. Walker KJ, Bouzubar N, Robertson J, Ellis IO, Elston CW, Blaney RW, et al. Immunocytochemical localization of estrogen receptor in human breast tissue. Cancer Res 1988; 48:6517-22.
28. Holmes FA, Fritsche HA, Loewy JW, Geitner AM, Sutton RC, Buzdar AU, et al. Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay. J Clin Oncol 1990;8:1025-35.
29. Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS, McCarty KS Jr. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res 1989;49:1052-6.
30. Buddoura FK, Cohen C, Unger ER, DeRose PB, Chenggis M. Image analysis for quantitation of estrogen receptor in formalin-fixed paraffin-embedded sections of breast carcinoma. Mod Pathol 1991;4:91-5.
31. Fritz P, Tuczek HV, Offinger B, Schwarzmann P, Schieszl S, Wu X, et al. Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients. Prog Histochem Cytochem 1992;26:146-58.
32. Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 1990;50:7057-61.
33. Pari FF, Posey YF. Discrepancies of the biochemical and immunohistochemical estrogen receptor assays in breast cancer. Hum Pathol 1988;19:960-6.
34. Hendricks JB, Wilkinson EJ. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors. Mod Pathol 1993;6:765-70.
35. Elias JM, Cartun RA, England DM, Hayes S, Hogenson CM, Hyder DM, et al. Interlaboratory comparison of estrogen receptor analysis in paraffin sections by a monoclonal antibody to estrophilin (H222). J Histotechnology 1993;16:57-63.
36. DeSombre ER, Thorpe SM, Rose C, Blough RR, Andersen KW, Rasmussen BB, et al. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer Res 1986;(Suppl)46:4256S-64S.